行情

DARE

DARE

Dare Bioscience
NASDAQ

实时行情|Nasdaq Last Sale

1.660
+0.040
+2.47%
盘后: 1.660 0 0.00% 19:59 01/17 EST
开盘
1.650
昨收
1.620
最高
1.680
最低
1.620
成交量
218.98万
成交额
--
52周最高
3.250
52周最低
0.6902
市值
2,769.45万
市盈率(TTM)
-1.6271
分时
5日
1月
3月
1年
5年

分析师评级

4位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

DARE 新闻

  • 沪指震荡上扬 中国央行4天投放1.1万亿
  • 新浪财经.28分钟前
  • 不甘心5G落后,日本拟2030年实现“6G通信”
  • 参考消息.2小时前
  • 英媒刊文:生产率下滑正困扰新兴经济体
  • 参考消息.4小时前
  • 戈恩为何决定逃亡?日媒揭秘:或因听闻审理将延期
  • 中国新闻网.4小时前

更多

所属板块

生物技术和医学研究
-0.16%
制药与医学研究
+0.06%

热门股票

名称
价格
涨跌幅

DARE 简况

Dare Bioscience, Inc., formerly Cerulean Pharma Inc., is a healthcare company. The Company is focused on the development and commercialization of products in women’s reproductive health. Its lead product candidate is Ovaprene, a clinical stage, non-hormonal contraceptive ring. The Company is developing Ovaprene to provide protection over multiple weeks of use and require no intervention at the time of intercourse. Ovaprene has a custom intravaginal ring design, with a permeable mesh in the center of the ring that creates a partial barrier to sperm, and a mechanism to release locally acting spermiostatic agents through the ring. The combination of these two complementary approaches produces attractive contraceptive efficacy outcomes that are consistent with the effective barrier option, the diaphragm, and short-acting hormonal options, such as oral pill, patches and vaginal ring.
展开

Webull提供Dare Bioscience Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。